Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended‐Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens

BACKGROUND AND OBJECTIVE: When patients seek to discontinue buprenorphine (BUP) treatment, monthly injectable extended‐release naltrexone (XR‐NTX) may help them avoid relapse. The efficacy of low ascending doses of oral NTX vs placebo for patients transitioning from BUP to XR‐NTX is evaluated in thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Comer, Sandra D., Mannelli, Paolo, Alam, Danesh, Douaihy, Antoine, Nangia, Narinder, Akerman, Sarah C., Zavod, Abigail, Silverman, Bernard L., Sullivan, Maria A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383475/
https://www.ncbi.nlm.nih.gov/pubmed/32246728
http://dx.doi.org/10.1111/ajad.13024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383475/
https://www.ncbi.nlm.nih.gov/pubmed/32246728
http://dx.doi.org/10.1111/ajad.13024

Ejemplares similares